Antagonists of growth hormone releasing hormone and bombesin inhibit the expression of EGF/HER receptor family in H-69 small cell lung carcinoma (Q40394065)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Antagonists of growth hormone releasing hormone and bombesin inhibit the expression of EGF/HER receptor family in H-69 small cell lung carcinoma	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Antagonists of growth hormone releasing hormone and bombesin inhibit the expression of EGF/HER receptor family in H-69 small cell lung carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

5

object named as

Gabor Halmos

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Celia A Kanashiro

1

object named as

Celia A Kanashiro

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

Jozsef L Varga

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Brian Hammann

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Marta Zarandi

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

226

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

123-131

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Increased activity of antagonists of growth hormone-releasing hormone substituted at positions 8, 9, and 10.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Epidermal growth factor-related peptides and their receptors in human malignancies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Suppression of tumor growth by growth hormone-releasing hormone antagonist JV-1-36 does not involve the inhibition of autocrine production of insulin-like growth factor II in H-69 small cell lung carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Epidermal growth factor receptor mutation type III transfected into a small cell lung cancer cell line is predominantly localized at the cell surface and enhances the malignant phenotype

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Antagonistic Analogs of Growth Hormone-releasing Hormone: New Potential Antitumor Agents

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Bombesin antagonists inhibit growth of MDA-MB-435 estrogen-independent breast cancers and decrease the expression of the ErbB-2/HER-2 oncoprotein and c-jun and c-fos oncogenes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Cancer statistics, 2004

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

The role of the insulin-like growth factor system in human cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Suppression of growth of H-69 small cell lung carcinoma by antagonists of growth hormone releasing hormone and bombesin is associated with an inhibition of protein kinase C signaling

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Bombesin stimulation of mitogenesis. Specific receptors, signal transduction, and early events

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

The ErbB/HER receptor protein-tyrosine kinases and cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Cell signaling by receptor tyrosine kinases

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Growth inhibition of experimental pancreatic cancers and sustained reduction in epidermal growth factor receptors during therapy with hormonal peptide analogs

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Targeted cytotoxic analogue of bombesin/gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Synergistic effects of bombesin and epidermal growth factor on cancers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Hypothalamic hormones and cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Novel targets for lung cancer therapy: part I.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.CANLET.2005.01.008

Identifiers

10.1016/J.CANLET.2005.01.008

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40394065&oldid=2119229513"